SCHEMBL4970531

SCHEMBL4970531

CCCCOC(=O)N1CCCC([C@@H](OCCN)c2cc(F)cc(Cl)c2)C1

nearest known ligand 0.50

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
REN P00797 20/20 0.50
CYP3A4 P08684 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4970536 1.00 REN (0.50) RENCYP3A4
SCHEMBL4968733 0.87 REN (0.56) RENCYP3A4
SCHEMBL4968724 0.87 REN (0.56) RENCYP3A4
SCHEMBL2325725 0.86 REN (0.51) RENCYP3A4
SCHEMBL2325731 0.86 REN (0.51) RENCYP3A4
SCHEMBL2325733 0.86 REN (0.51) RENCYP3A4
SCHEMBL4981525 0.85 REN (0.51) RENCYP3A4
SCHEMBL4981529 0.85 REN (0.51) RENCYP3A4
SCHEMBL4974711 0.77 REN (0.43) RENCYP3A4
SCHEMBL5599014 0.77 REN (0.57) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966139-A1 ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2008-09-10 EP disclosed
WO-2007070201-A1 ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2007-06-21 WO disclosed